PrimeRFP SCOUT · Federal Contract Recompete Brief

75N91025C00039NOVEL theranostic radioligands targeting — Matrisome Bio, Inc

Matrisome Bio, Inc holds $354K across 1 federal awards, concentrated at Department of Health and Human Services (HHS). Competition previously drew 55 offers. Set-aside status: Small business. PoP ended Sep 14, 2026 — the usual 12–18 month planning window is closed; recompete action looks late or overdue.

Nih Nci
Awarding office
Matrisome Bio, Inc
Recipient
Sep 14, 2026
PoP end
$354K
Obligated
$354K
Potential
541715
NAICS
AN12
PSC
Small business
Set-aside
55 bidders on last award

Watch this recompete

One email. No account. We ping you if the window moves.

Contract facts

Small business
Contract number75N91025C00039
AgencyNih Nci
Awarding officeNih Nci
Awarding agencyDepartment of Health and Human Services (HHS)
Funding agencyDepartment of Health and Human Services (HHS)
IncumbentMatrisome Bio, Inc
CAGE07E56
UEIDWR8LNQUCJR8
NAICS541715
PSCAN12
Place of performanceCAMBRIDGE MA
Pricing typeFirm Fixed Price
Extent competedFull And Open Competition After Exclusion Of Sources
PoP startSep 15, 2025
PoP end (current)Sep 14, 2026
Obligated$354K
Current value$354K
Potential value$354K

NOVEL THERANOSTIC RADIOLIGANDS TARGETING DISEASE-SPECIFIC EXTRACELLULAR MATRIX COMPONENTS SPECIFIC TO TUMOR AND METASTATIC LESIONS IN PATIENTS SUFFERING FROM HEREDITARY BREAST AND OVARIAN CANCER (HBOC) is a federal Small business award for Nih Nci held by Matrisome Bio, Inc. Estimated value $354K ($354K obligated). Current period of performance ends Sep 14, 2026. Last award drew 55 bidders. Place of performance: CAMBRIDGE MA.

NOVEL THERANOSTIC RADIOLIGANDS TARGETING DISEASE-SPECIFIC EXTRACELLULAR MATRIX COMPONENTS SPECIFIC TO TUMOR AND METASTATIC LESIONS IN PATIENTS SUFFERING FROM HEREDITARY BREAST AND OVARIAN CANCER (HBOC)

Recompete timing

Public
● Past PoP end (13 days ago)

Current PoP ended Sep 14, 2026 (13 days ago). The usual 12–18 month agency planning window is closed — recompete action looks late / overdue relative to a normal cycle. Watch for bridge orders, follow-ons, or a new solicitation.

Bonuses end Sept 30

Want the durability read on 75N91025C00039? One Pursuit Analysis, $500, inside 48 business hours.

  • 48 business hours
  • $500
  • Credits toward the Pack
Buy one Pursuit Analysis — $500

Incumbent footprint

Public record

Matrisome Bio, Inc — $354K obligated across 1 awards (firm-wide, all agencies).

Sole agency: Department of Health and Human Services (HHS)
Department of Health and Human Services (HHS)$354K · 100% of firm total
Open full company profile →

Query this award live in SCOUT via MCP — personalized scoring, watchlists, and capture workflow across the corpus. Learn about SCOUT MCP →

More in SCOUT
Size up the competition →Research the incumbent →

Frequently asked questions

What is contract 75N91025C00039?

75N91025C00039 (NOVEL theranostic radioligands targeting) is a Nih Nci award with a potential value of $354K, currently held by Matrisome Bio, Inc. Figures are USASpending-sourced public-record facts plus SCOUT recompete analysis.

Which office awarded 75N91025C00039?

Nih Nci awarded 75N91025C00039 to Matrisome Bio, Inc (potential $354K).

Who is the incumbent on 75N91025C00039?

Matrisome Bio, Inc is the incumbent with $354K across 1 related awards in SCOUT’s public footprint. The current period of performance ends Sep 14, 2026.

When does Matrisome Bio, Inc’s 75N91025C00039 come up for recompete?

SCOUT tracks a period-of-performance end of Sep 14, 2026. Actual solicitation timing can shift with extensions, bridges, or consolidations.

Want the durability read on 75N91025C00039? One Pursuit Analysis, $500, inside 48 business hours.

One Pursuit Analysis is $500 and credits toward the Sprint Pack. Delivery is 48 business hours. Start with the free Exposure Check if you want the list first.

Get the free Exposure Check

No card · under a minute · then the Sprint menu

Buy one Pursuit Analysis — $500

Credits toward the Sprint Pack

Compare plans

Data: Showing contracts ≥ $100K from federal procurement records (FPDS-NG, SAM.gov, and related repositories), normalized by PrimeRFP SCOUT. Each row keyed by Award ID (PIID); task orders appear as independent rows.

Data as of · refreshed monthlyLatest procurement action
Sources: USASpending, FPDS, SAM.gov · Public-record facts + SCOUT analysis shown above; personalized scoring in SCOUT.
primerfp.com/intel/contract/75N91025C00039